TrialStem cells translational medicine2021

Mesenchymal stromal cells in human immunodeficiency virus-infected patients with discordant immune response: Early results of a phase I/II clinical trial.

María Trujillo-Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.